We hypothesized that promoter hypermethylation in NPC cells might inhibit the paracrine effects of FSTL1 secretion and thus block the cancer–stromal interaction, thereby allowing NPC cells to escape an attack of stromal immune cells. This evidence concerns the gene FSTL1 and cancer.